Sitagliptin Umbilical Cord Blood Transplant Study

NCT00862719 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid, Acute
Acute Lymphoblastic Leukemia
Myelodysplasia
Leukemia, Myelogenous, Chronic
Lymphoma, Non-Hodgkin

Interventions

DRUG: Sitagliptin

Sponsor

Indiana University